Amanda Cox

The window of therapeutic opportunity in multiple sclerosis

Alasdair Coles, Amanda Cox, Emmanuelle Le Page et al. · Journal of Neurology · 2005 · 505 citations

Life Sciences, Neurology, Neuroscience +14

IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)

Joanne Jones, Chia‐Ling Phuah, Amanda Cox et al. · Journal of Clinical Investigation · 2009 · 298 citations · Full text

Life Sciences, Immunology, Autoimmunity +13

Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis

Amanda Cox, Sara Thompson, Joanne Jones et al. · European Journal of Immunology · 2005 · 290 citations · Full text

Life Sciences, Cell Biology, Immunology +13

B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis

Sara Thompson, Joanne Jones, Amanda Cox et al. · Journal of Clinical Immunology · 2009 · 229 citations

Life Sciences, Immunology, Neurology +14

Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience

Nicolas Leboulanger, P. Fayoux, N. Teissier et al. · International Journal of Pediatric Otorhinolaryngology · 2010 · 110 citations

Medicine, Otolaryngology, Pharmacology +14